Trials / Unknown
UnknownNCT05517993
Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension
Effect of Gui-Lu-Er-Xian-Jiao-Wan on Intradialytic Hypotension: a Randomized Crossover Pilot Trial
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Intradialytic hypotension (IDH), a common complication during hemodialysis (HD) could increase patients' morbidity and mortality. Previous studies considered that some Chinese herbal medicine (CHM) plays a complementary role in reducing the frequency of IDH. This trial is aimed to investigate the effect of Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) in patients with intradialytic hypotension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gui-Lu-Er-Xian-Jiao-Wan | Gui-Lu-Er-Xian-Jiao-Wan (GLEXJW) is an ancient CHM formula, mainly originating from processed tortoise shells, antlers, Ginseng, and wolfberry. |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2024-07-31
- Completion
- 2024-12-31
- First posted
- 2022-08-26
- Last updated
- 2022-08-26
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05517993. Inclusion in this directory is not an endorsement.